Ligand strikes up to $47M financing deal with AvenCell Therapeutics
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 314.78 +8.38 (2.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $306.40 | 52 Week High | $139.79 | |||
| Open | $305.36 | 52 Week Low | $82.07 | |||
| Day High | $317.64 | P/E | 732.05 | |||
| Day Low | $303.93 | EPS | $0.43 | |||
| Volume | 222,681 | |||||
